Harbin Pharmaceutical Group Co., Ltd. is a Sino-foreign joint venture. State-owned shares account for 45%, CITIC Capital Iceland Investment Co., Ltd. and Huaping Iceland Investment Co., Ltd. each hold 22.5%, and Harbin State-owned Enterprise Restructuring Management Consulting Co., Ltd. holds 10%. The State-owned Assets Supervision and Administration Commission of Harbin is the largest shareholder, and it has two listed companies, Harbin Pharmaceutical Co., Ltd. and Renmin Tongtai.
With strong strength, the Group has won many awards, such as China 100 Most Valuable Consumer Brand, China Public Welfare Brand Award and China Industry Leading Brand. Harbin Pharmaceutical Group Co., Ltd. (a large enterprise group integrating pharmaceutical manufacturing, trade and scientific research) is the first listed company in the pharmaceutical industry in China and the first listed company in Heilongjiang Province.